Australia's Emyria rises on potential listing in Frankfurt exchange

Emyria

12/02/2026 04:59

** Shares of Australia's Emyria EMD.AX rise as much as 5.5% to A$0.058, their highest level since February 5

** The early-stage drug developer says EMD securities can now be traded in Europe on Frankfurt Open Market

** "European investor outreach is a logical extension of our strategy to improve accessibility for institutional and specialist healthcare investors," says Greg Hutchinson, executive chairman of Emyria

** Stock down 1.7% YTD, including session's moves

 (Reporting by Aamir Sheik Khalid in Bengaluru)

 ((Aamir.SheikKhalid@thomsonreuters.com))